Asthma pathogenesis and the implications for therapy in children.
Gaining greater insight into the pathogenesis of asthma has redefined the approach to treatment of children with asthma. Clearly, the Expert Panel of the National Heart, Lung, and Blood Institute National Education Program has played a major role in taking the message to a wide audience of health care providers. Although only early trends are evident at this point in time, within several years therapeutic trends underway currently will be more commonplace, and we may observe how asthma continues to impact society and our health care system. The approach to therapy will continue to evolve and most likely be controversial for years to come.
Hill
M
M
Department of Pediatrics, University of Colorado Health Sciences Center, Denver.
Szefler
S J
SJ
Larsen
G L
GL
D001249:Asthma / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D016535:Bronchial Hyperreactivity / Q000209:etiology* / Q000276:immunology; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002648:Child; D004205:Cromolyn Sodium / Q000627:therapeutic use*; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D009420:Nervous System / Q000503:physiopathology; D012137:Respiratory System / Q000473:pathology
D001993:Bronchodilator Agents; D005938:Glucocorticoids; D004205:Cromolyn Sodium